InsiderFlow

JSPR

Jasper Therapeutics, Inc.$0.92-0.01 (-0.84%)
Prev Close$0.93·MCap$21.3M·P/E·Vol175.5K·Yield

Buys (12M)

2

$148.2K

Sells (12M)

0

$0.00

Net Activity

Net Buyer

$148.2K

Active Insiders

2

last 12 mo

Over the past 12 months, insider activity at Jasper Therapeutics, Inc. (JSPR) has been exclusively buying, with 2 insider purchases totaling $148.2K and 0 insider sales totaling $0.00. The most recent insider transaction was by Lucas Svetlana (Director), who purchased $48.6K worth of shares on Sep 22, 2025. Jasper Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $21.3M.

JSPR Insider Trading Activity

DateInsiderTypeValue
Sep 22, 2025 Lucas SvetlanaBuy$48.6K
Sep 22, 2025 WIGGANS THOMAS GBuy$99.6K
Dec 12, 2024 Mahal Jeetinder SinghSell$19.9K
Sep 12, 2024 Mahal Jeetinder SinghSell$19.1K
Jun 12, 2024 Mahal Jeetinder SinghSell$21.7K
Mar 12, 2024 Mahal Jeetinder SinghSell$23.8K
Feb 9, 2024 Velan Capital Investment Management LPBuy$4.53M2.2% OS
Nov 30, 2023 WIGGANS THOMAS GBuy$6.5K
Nov 22, 2023 WIGGANS THOMAS GBuy$6.4K
Nov 20, 2023 WIGGANS THOMAS GBuy$18.2K
Oct 13, 2023 Lis WilliamSell$6.8K
Jun 13, 2023 Mahal Jeetinder SinghSell$14.9K
Apr 14, 2023 EMSTER KURT VONSell$13.5K
Apr 14, 2023 French Anna LouiseSell$10.4K
Apr 14, 2023 Lis WilliamSell$12.2K
Apr 11, 2023 Qiming U.S. Healthcare Fund II, L.P.Buy$4.00M16.4% OS
Jan 26, 2023 ROCHE HOLDING LTDSell$141.8K
Jun 28, 2022 Lis WilliamSell$101.4K
Apr 23, 2021 GLAZER CAPITAL, LLCSell$1.52M0.9% OS
Apr 21, 2021 GLAZER CAPITAL, LLCSell$20.5K

JSPR Insider Buying Activity

The following table shows recent insider purchases of Jasper Therapeutics, Inc. (JSPR) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Sep 22, 2025 Lucas SvetlanaBuy$48.6K
Sep 22, 2025 WIGGANS THOMAS GBuy$99.6K
Feb 9, 2024 Velan Capital Investment Management LPBuy$4.53M2.2% OS
Nov 30, 2023 WIGGANS THOMAS GBuy$6.5K
Nov 22, 2023 WIGGANS THOMAS GBuy$6.4K
Nov 20, 2023 WIGGANS THOMAS GBuy$18.2K
Apr 11, 2023 Qiming U.S. Healthcare Fund II, L.P.Buy$4.00M16.4% OS

JSPR Insider Selling Activity

The following table shows recent insider sales of Jasper Therapeutics, Inc. (JSPR) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Dec 12, 2024 Mahal Jeetinder SinghSell$19.9K
Sep 12, 2024 Mahal Jeetinder SinghSell$19.1K
Jun 12, 2024 Mahal Jeetinder SinghSell$21.7K
Mar 12, 2024 Mahal Jeetinder SinghSell$23.8K
Oct 13, 2023 Lis WilliamSell$6.8K
Jun 13, 2023 Mahal Jeetinder SinghSell$14.9K
Apr 14, 2023 EMSTER KURT VONSell$13.5K
Apr 14, 2023 French Anna LouiseSell$10.4K
Apr 14, 2023 Lis WilliamSell$12.2K
Jan 26, 2023 ROCHE HOLDING LTDSell$141.8K
Jun 28, 2022 Lis WilliamSell$101.4K
Apr 23, 2021 GLAZER CAPITAL, LLCSell$1.52M0.9% OS
Apr 21, 2021 GLAZER CAPITAL, LLCSell$20.5K

JSPR Insiders

WIGGANS THOMAS G

Director

Bought $130.7K
4 tradesLast: Sep 22, 2025
Lucas Svetlana

Director

Bought $48.6K
1 tradesLast: Sep 22, 2025
Mahal Jeetinder Singh

See Remarks

Sold $99.4K
5 tradesLast: Dec 12, 2024
Velan Capital Investment Management LP

10% Owner

Bought $4.53M
1 tradesLast: Feb 9, 2024
Lis William

Director

Sold $120.5K
3 tradesLast: Oct 13, 2023
EMSTER KURT VON

Director

Sold $13.5K
1 tradesLast: Apr 14, 2023
French Anna Louise

Director

Sold $10.4K
1 tradesLast: Apr 14, 2023
Qiming U.S. Healthcare Fund II, L.P.

10% Owner

Bought $4.00M
1 tradesLast: Apr 11, 2023
ROCHE HOLDING LTD

10% Owner

Sold $141.8K
1 tradesLast: Jan 26, 2023
GLAZER CAPITAL, LLC

10% Owner

Sold $1.54M
2 tradesLast: Apr 23, 2021